GI Oncology
News
HLA class I plays role in aspirin’s benefit in colon ca
Major finding: Low-dose aspirin cut the risk of death in half in colon cancer patients with tumors expressing HLA class I.Data source: Microarray...
News
Sulfasalazine may make radiation-induced diarrhea worse
Major finding: In all, 29% of patients who received sulfasalazine prophylactically had grade 3 or 4 diarrhea, compared with 11% of patients who...
News
Lanreotide scores big against GI and pancreatic neuroendocrine tumors
Major finding: Progression-free survival was 66% in the group treated with the somatostatin analogue, compared with 22% in the placebo group (HR,...
News
Adjuvant gemcitabine a plus for resected pancreatic cancer
Major finding: Disease-free survival (13.4 vs. 6.7 months) and overall survival (22.8 vs. 20.2 months) were significantly greater with gemcitabine...
News
Polypectomy bleed risk low in patients on antiplatelet agents
Major finding: Patients taking antiplatelet agents can expect a 2.4% risk of clinically important bleeds within 30 days from polypectomy; it may...
News
Selective screening missed 13% of Lynch syndrome–associated colorectal cancers
Major finding: Left-sided tumors with high microsatellite instability (n = 12; 57%) were more likely to be Lynch syndrome–related than were right-...
News
Colorectal cancer screening cuts long-term mortality
Major finding: The multivariate hazard ratios for colorectal cancer were 0.57 after endoscopy plus removal of adenomatous polyps (polypectomy), 0....
News
FDA approves first generic capecitabine
News
FDA expands Abraxane approval to include advanced pancreatic cancer
From the AGA Journals
Hybrid colorectal cancer screening model reduced cancer rate
Major finding: A hybrid screening strategy reduced colorectal cancer by 73%.Data source: A cost-effectiveness analysis using a simulation model in...